Clinical Trials Logo

EGFR Exon 20 Insertion Mutation clinical trials

View clinical trials related to EGFR Exon 20 Insertion Mutation.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03805841 Terminated - NSCLC Stage IIIB Clinical Trials

Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions

RAIN
Start date: March 13, 2019
Phase: Phase 2
Study type: Interventional

Open-label, Phase 2, single treatment arm, 3 cohorts